FR2872705B1 - Compositions contenant du nicorandil, procede de preparation et utilisation - Google Patents

Compositions contenant du nicorandil, procede de preparation et utilisation

Info

Publication number
FR2872705B1
FR2872705B1 FR0407590A FR0407590A FR2872705B1 FR 2872705 B1 FR2872705 B1 FR 2872705B1 FR 0407590 A FR0407590 A FR 0407590A FR 0407590 A FR0407590 A FR 0407590A FR 2872705 B1 FR2872705 B1 FR 2872705B1
Authority
FR
France
Prior art keywords
preparation
compositions containing
containing nicorandil
nicorandil
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0407590A
Other languages
English (en)
Other versions
FR2872705A1 (fr
Inventor
Mathieu Nogent
Thierry Bonhomme
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0407590A priority Critical patent/FR2872705B1/fr
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Priority to KR1020077000276A priority patent/KR20070030262A/ko
Priority to CN200580022748A priority patent/CN100591356C/zh
Priority to EA200700191A priority patent/EA012967B1/ru
Priority to NZ552983A priority patent/NZ552983A/en
Priority to JP2007519838A priority patent/JP2008505873A/ja
Priority to ZA200700704A priority patent/ZA200700704B/xx
Priority to PCT/FR2005/001730 priority patent/WO2006016040A1/fr
Priority to BRPI0513005-0A priority patent/BRPI0513005A/pt
Priority to AU2005271131A priority patent/AU2005271131B2/en
Priority to CA002570863A priority patent/CA2570863A1/fr
Priority to MXPA06015151A priority patent/MXPA06015151A/es
Priority to EP05786080A priority patent/EP1776093A1/fr
Publication of FR2872705A1 publication Critical patent/FR2872705A1/fr
Priority to US11/642,575 priority patent/US20070190134A1/en
Priority to IL180285A priority patent/IL180285A0/en
Priority to NO20070186A priority patent/NO20070186L/no
Priority to MA29654A priority patent/MA28783B1/fr
Priority to HK07112888.3A priority patent/HK1107256A1/xx
Publication of FR2872705B1 publication Critical patent/FR2872705B1/fr
Application granted granted Critical
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0407590A 2004-07-08 2004-07-08 Compositions contenant du nicorandil, procede de preparation et utilisation Expired - Fee Related FR2872705B1 (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FR0407590A FR2872705B1 (fr) 2004-07-08 2004-07-08 Compositions contenant du nicorandil, procede de preparation et utilisation
EP05786080A EP1776093A1 (fr) 2004-07-08 2005-07-05 Compositions contenant du nicorandil, procede de preparation et utilisation
CN200580022748A CN100591356C (zh) 2004-07-08 2005-07-05 含有尼可地尔的组合物、制备方法和应用
NZ552983A NZ552983A (en) 2004-07-08 2005-07-05 Compositions containing nicorandil, preparation method and use
JP2007519838A JP2008505873A (ja) 2004-07-08 2005-07-05 ニコランジルを含む組成物、調製方法及び使用
ZA200700704A ZA200700704B (en) 2004-07-08 2005-07-05 Compositions containing nicorandil, preparation method and use
PCT/FR2005/001730 WO2006016040A1 (fr) 2004-07-08 2005-07-05 Compositions contenant du nicorandil, procede de preparation et utilisation
BRPI0513005-0A BRPI0513005A (pt) 2004-07-08 2005-07-05 composições contendo nicorandil, processo de preparo e utilização
MXPA06015151A MXPA06015151A (es) 2004-07-08 2005-07-05 Composiciones que contienen nicorandil, procedimiento de preparacion y utilizacion.
CA002570863A CA2570863A1 (fr) 2004-07-08 2005-07-05 Compositions contenant du nicorandil, procede de preparation et utilisation
KR1020077000276A KR20070030262A (ko) 2004-07-08 2005-07-05 니코란딜을 함유하는 조성물, 제조 방법 및 용도
EA200700191A EA012967B1 (ru) 2004-07-08 2005-07-05 Композиции, содержащие никорандил, способ получения и применение
AU2005271131A AU2005271131B2 (en) 2004-07-08 2005-07-05 Compositions containing Nicorandil, preparation method and use
US11/642,575 US20070190134A1 (en) 2004-07-08 2006-12-20 Compositions containing nicorandil, preparation method and use
IL180285A IL180285A0 (en) 2004-07-08 2006-12-24 Compositions containing nicorandil, preparation method and use
NO20070186A NO20070186L (no) 2004-07-08 2007-01-11 Sammensetninger inneholdende nicorandil, fremstillingsfremgangsmate og anvendelse av sammensetningen
MA29654A MA28783B1 (fr) 2004-07-08 2007-02-05 Compositions contenant du nicorandil, procede de preparation et utilisation
HK07112888.3A HK1107256A1 (en) 2004-07-08 2007-11-26 Compositions containing nicorandil, preparation method and use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0407590A FR2872705B1 (fr) 2004-07-08 2004-07-08 Compositions contenant du nicorandil, procede de preparation et utilisation

Publications (2)

Publication Number Publication Date
FR2872705A1 FR2872705A1 (fr) 2006-01-13
FR2872705B1 true FR2872705B1 (fr) 2008-07-18

Family

ID=34950297

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0407590A Expired - Fee Related FR2872705B1 (fr) 2004-07-08 2004-07-08 Compositions contenant du nicorandil, procede de preparation et utilisation

Country Status (18)

Country Link
US (1) US20070190134A1 (fr)
EP (1) EP1776093A1 (fr)
JP (1) JP2008505873A (fr)
KR (1) KR20070030262A (fr)
CN (1) CN100591356C (fr)
AU (1) AU2005271131B2 (fr)
BR (1) BRPI0513005A (fr)
CA (1) CA2570863A1 (fr)
EA (1) EA012967B1 (fr)
FR (1) FR2872705B1 (fr)
HK (1) HK1107256A1 (fr)
IL (1) IL180285A0 (fr)
MA (1) MA28783B1 (fr)
MX (1) MXPA06015151A (fr)
NO (1) NO20070186L (fr)
NZ (1) NZ552983A (fr)
WO (1) WO2006016040A1 (fr)
ZA (1) ZA200700704B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2098249B1 (fr) 2008-03-05 2012-10-24 Rivopharm SA Véhicules de nicorandil dotés d'une stabilité améliorée
CN115429763B (zh) * 2021-06-02 2024-01-02 北京四环科宝制药股份有限公司 尼可地尔片剂及其制备方法
CN114732792A (zh) * 2022-03-25 2022-07-12 北京诺康达医药科技股份有限公司 一种尼可地尔口腔崩解片及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3915959A (en) * 1974-03-15 1975-10-28 Crown Zellerbach Corp Activated alkali cellulose and derivatives formed therefrom and a process for making the same
JPS57145659A (en) * 1981-03-06 1982-09-08 Chugai Pharmaceutical Co Ltd Production of tablet
KR940000232B1 (ko) * 1986-01-17 1994-01-12 쥬우가이세이야꾸 가부시끼가이샤 니코란딜 제제의 안정화 방법
ZA87279B (en) * 1986-01-17 1987-09-30 Chugai Pharmaceutical Co Ltd Method for production of stable nicorandil preparation
JP2512302B2 (ja) * 1986-03-19 1996-07-03 中外製薬株式会社 ニコランジル安定化製剤の製造方法
JP2936376B2 (ja) * 1993-09-03 1999-08-23 小林化工株式会社 ニコランジル錠剤の製法
JP3503222B2 (ja) * 1994-11-07 2004-03-02 東和薬品株式会社 ニコランジルの安定化錠剤の製造方法
JPH08175996A (ja) * 1994-12-22 1996-07-09 Taiyo Yakuhin Kogyo Kk ニコランジル安定化固形製剤の製法
JP2535141B2 (ja) * 1995-01-17 1996-09-18 中外製薬株式会社 フマル酸含有徐放性製剤
JP3947582B2 (ja) * 1995-08-15 2007-07-25 中外製薬株式会社 不安神経症治療剤
TW458776B (en) * 1995-08-15 2001-10-11 Chugai Pharmaceutical Co Ltd Pharmaceutical composition for the treatment of anxiety neurosis
JPH10231241A (ja) * 1997-02-19 1998-09-02 T T S Gijutsu Kenkyusho:Kk 服用に水を必要としない錠剤、並びにドライエマルションおよびその製造方法
JPH11189547A (ja) * 1997-12-26 1999-07-13 Taisho Pharmaceut Co Ltd 安定化されたニコランジル製剤及びその製造方法
US6544554B1 (en) * 1998-05-15 2003-04-08 Chugai Seiyaku Kabushiki Kaisha Regulated release preparations
JP2001010950A (ja) * 1999-06-29 2001-01-16 Taiyo Yakuhin Kogyo Kk 安定で良好な薬物放出を有する医薬組成物

Also Published As

Publication number Publication date
FR2872705A1 (fr) 2006-01-13
ZA200700704B (en) 2008-10-29
EP1776093A1 (fr) 2007-04-25
JP2008505873A (ja) 2008-02-28
AU2005271131A1 (en) 2006-02-16
WO2006016040A1 (fr) 2006-02-16
NZ552983A (en) 2010-07-30
NO20070186L (no) 2007-01-31
US20070190134A1 (en) 2007-08-16
KR20070030262A (ko) 2007-03-15
HK1107256A1 (en) 2008-04-03
MXPA06015151A (es) 2007-03-26
EA012967B1 (ru) 2010-02-26
EA200700191A1 (ru) 2007-06-29
IL180285A0 (en) 2007-07-04
CN1980644A (zh) 2007-06-13
MA28783B1 (fr) 2007-08-01
CN100591356C (zh) 2010-02-24
CA2570863A1 (fr) 2006-02-16
BRPI0513005A (pt) 2008-04-22
AU2005271131B2 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
FR15C0037I2 (fr) Compositions monodisperses contenant du naloxol pegyle
FR2884821B1 (fr) Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
DK2069352T3 (da) Bestemte kemiske enheder, sammensætninger og fremgangsmåder
DE602005001560D1 (de) Zugangskanüle
DK1765327T3 (da) Forbindelser, sammensætninger og fremgangsmåder
DK1827412T3 (da) Sammensætninger til anvendelse i kirurgi
PT1506781E (pt) Composicao para tratamento vaginal
DK1898904T3 (da) 1-[(3-Hydrroxy-adamant-1-ylamino)-acetyl]-pyrrolidin-2(S)-carbonitril-formulering med modificeret frigivelse
IL175300A0 (en) Indirubin-type compounds, compositions, and methods for their use
ATE462692T1 (de) 3-amino-1-arylpropyl-indole als monoamin- wiederaufnahmehemmer
DK1692242T3 (da) Viskoelastisk syre
ZA200606606B (en) Substituted Azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments
CL2007002376A1 (es) Compuestos derivados de pirrol sustituido; proceso de preparacion; composicion farmaceutica; y uso en enfermedades bacterianas.
FR2881426B1 (fr) Pyrolles et imidazoles substitues, compositions les contenant, procede de frabrication et utilisation
FR2900819B1 (fr) Compose de type bis-uree, composition le comprenant, utilisation et procede de traitement cosmetique
EP1819323A4 (fr) Composition pharmaceutique renfermant un agent d'anti-nucleation
DK1587478T3 (da) Farmaceutisk sammensætning
IL179530A0 (en) Novel compounds, pharmaceutical compositions containing same and methods of use for same
GB0502787D0 (en) Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use
ATE372992T1 (de) Indanyl-piperazinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
FR2903406B1 (fr) Derives de pyrazolylbenzimidazole,compositions les contenant et utilisation
FR2908409B1 (fr) Pyrazoles substituees,compositions les contenant,procede de fabrication et utilisation
DE112005000713A5 (de) Reinigungsanlage
DE502005007336D1 (de) Reinigungsmittel, enthaltend Polyolhydroxyalkylether
FR2883184B1 (fr) Composition de spirulines riche en principes actifs, procede d'obtention et utilisation

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130329